Latest updates on cell therapy, medical tourism, and healthcare policy for international patients. AI-curated with sources cited.
China's corneal transplant field has recently seen dual benefits: on one hand, a new generation of bioengineered corneas (such as acellular porcine corneal stroma) has demonstrated comparable efficacy to traditional donor corneas in clinical trials, with a 12-month graft survival rate of 92%; on the
Read articleRecently, a multicenter study published in the *Journal of Clinical Oncology* demonstrated that liquid biopsy-based multi-cancer early detection (MCED) technology can identify over 50 cancer types in asymptomatic individuals, with an overall sensitivity of 51.5% and specificity of 99.5%.
Read articleThe Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Tianjin), recently released its 2025 clinical data on autologous hematopoietic stem cell transplantation (ASCT): For multiple myeloma patients, after adopting the modified BuMel (busulfan combined with melp
Read articleBrain-computer interface (BCI) has reached a milestone in neural rehabilitation. Recently, a multicenter clinical trial published in *Nature Medicine* demonstrated that a non-invasive BCI-driven exoskeleton device improved upper limb Fugl-Meyer scores by an average of 12.3 points in chronic stroke p
Read articleChina's CAR-T cell therapy has achieved significant clinical progress in 2025. According to the latest data from the Center for Drug Evaluation of the National Medical Products Administration, domestic CAR-T products have achieved a complete remission (CR) rate of 72.3% in patients with relapsed/ref
Read articleA multicenter real-world study covering global sites shows that CAR-T cell therapy for relapsed/refractory lymphoma achieves a complete remission (CR) rate of 58%, with median overall survival extended to 24.3 months.
Read articleIn the first quarter of 2025, the number of installed Da Vinci surgical robots in mainland China exceeded 380 units, with cumulative surgeries surpassing 400,000 cases, maintaining an annual growth rate of over 30%.
Read articleRecently, the National Medical Products Administration approved multiple clinical trial applications for stem cell therapy products, covering indications such as knee cartilage repair and diabetic foot ulcers.
Read articleProton and heavy ion therapy is becoming a hotspot in tumor radiotherapy due to its precise targeting of tumors and reduced damage to normal tissues. According to statistics from the Particle Therapy Co-Operative Group (PTCOG), over 300,000 patients worldwide have received this treatment.
Read articleGet the latest medical insights and healthcare news delivered to your inbox.
